Yan Ling Selected Research

9-chloro-2-methylellipticinium acetate

7/2007

Bioinformatics-based discovery and characterization of an AKT-selective inhibitor 9-chloro-2-methylellipticinium acetate (CMEP) in breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yan Ling Research Topics

Disease

12	Neoplasms (Cancer) 03/2021 - 07/2003
6	Inflammation (Inflammations) 01/2020 - 02/2011
5	Tuberculosis (Tuberculoses) 10/2022 - 10/2015
5	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 11/2003
4	Type 2 Diabetes Mellitus (MODY) 01/2020 - 04/2011
4	Sepsis (Septicemia) 03/2015 - 01/2010
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 08/2011
3	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2018
3	Pre-Eclampsia (Preeclampsia) 01/2021 - 01/2018
3	Hypertension (High Blood Pressure) 01/2019 - 01/2017
3	Hypertriglyceridemia 05/2017 - 01/2016
3	Pancreatitis 02/2016 - 07/2008
3	Infections 02/2014 - 06/2012
3	Hyperglycemia 06/2008 - 05/2007
2	Graves Disease (Basedow Disease) 01/2022 - 01/2020
2	Critical Illness (Critically Ill) 01/2022 - 09/2012
2	Carcinogenesis 01/2021 - 10/2011
2	Neoplasm Metastasis (Metastasis) 03/2020 - 10/2014
2	Atherosclerosis 01/2020 - 08/2007
2	Coronary Artery Disease (Coronary Atherosclerosis) 05/2018 - 01/2017
2	Coronary Disease (Coronary Heart Disease) 10/2017 - 05/2017
2	Insulin Resistance 10/2017 - 09/2011
2	Reperfusion Injury 04/2015 - 10/2012
2	Cognitive Dysfunction 07/2009 - 09/2007
2	Breast Neoplasms (Breast Cancer) 11/2008 - 07/2007
1	Communicable Diseases (Infectious Diseases) 11/2022
1	Cardiotoxicity 10/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Adenocarcinoma of Lung 07/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Adenocarcinoma 01/2021
1	Inborn Urea Cycle Disorders 01/2021
1	Liver Neoplasms (Liver Cancer) 01/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Heart Failure 12/2020
1	Lung Neoplasms (Lung Cancer) 03/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 03/2021 - 11/2003
6	HMGB1 Protein (HMG1)IBA 01/2018 - 07/2008
6	Glucose (Dextrose)FDA LinkGeneric 10/2017 - 08/2007
4	Pharmaceutical PreparationsIBA 11/2022 - 07/2003
3	LipidsIBA 10/2022 - 04/2011
3	ApolipoproteinsIBA 01/2020 - 09/2007
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 12/2019
3	Triglycerides (Triacylglycerol)IBA 01/2019 - 05/2011
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 07/2013
3	oxidized low density lipoproteinIBA 01/2019 - 04/2011
3	Small Interfering RNA (siRNA)IBA 04/2015 - 08/2011
3	Insulin-Like Growth Factor I (IGF-1)IBA 06/2008 - 05/2007
2	LactamsIBA 11/2022 - 01/2020
2	EnzymesIBA 10/2022 - 10/2007
2	AlbuminsIBA 01/2022 - 05/2018
2	alectinibIBA 01/2021 - 01/2021
2	neurotoxic esteraseIBA 01/2021 - 01/2018
2	Immune Checkpoint InhibitorsIBA 01/2021 - 03/2020
2	Blood Glucose (Blood Sugar)IBA 01/2020 - 10/2017
2	Apolipoproteins E (ApoE)IBA 01/2020 - 09/2007
2	AldosteroneIBA 01/2020 - 09/2011
2	HDL CholesterolIBA 01/2019 - 05/2017
2	CytokinesIBA 01/2018 - 01/2015
2	Natalizumab (Tysabri)FDA Link 12/2017 - 06/2017
2	aducanumabIBA 01/2017 - 01/2016
2	Apolipoprotein C-II (ApoC2)IBA 02/2016 - 01/2016
2	Amyloid (Amyloid Fibrils)IBA 01/2016 - 11/2003
2	LigandsIBA 10/2014 - 08/2007
2	Uric Acid (Urate)IBA 11/2013 - 02/2012
1	Cephalosporins (Cephalosporin Antibiotics)IBA 11/2022
1	phosphopantetheinyl transferaseIBA 10/2022
1	benzamideIBA 10/2022
1	Virulence Factors (Pathogenicity Factors)IBA 10/2022
1	Ion Channels (Ion Channel)IBA 10/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	HDL LipoproteinsIBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 07/2021
1	Zinc Oxide FDA Link 03/2021
1	Trastuzumab (Herceptin)FDA Link 01/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2021
1	4-phenylbutyric acid (Buphenyl)FDA Link 01/2021
1	human ERBB2 proteinIBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	CateninsIBA 01/2021
1	NucleotidesIBA 01/2021
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2021
1	Proton Pump InhibitorsIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	4-phenylbutylamineIBA 01/2021
1	CrizotinibIBA 01/2021
1	lorlatinibIBA 01/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021
1	TabletsIBA 12/2020
1	Iodide Peroxidase (Deiodinase)IBA 01/2020
1	Mixed Function Oxygenases (Monooxygenases)IBA 01/2020
1	AsparagineIBA 01/2020
1	AntibodiesIBA 01/2020
1	apatinibIBA 01/2020

Therapy/Procedure

8	Therapeutics 01/2021 - 05/2005
3	Drug Therapy (Chemotherapy) 01/2021 - 10/2007
1	Immunotherapy 03/2020